Use of a Decision Aid to Resolve Uncertainty About Radioactive Iodine Treatment in Patients With Intermediate Risk Thyroid Cancer

NANot yet recruitingINTERVENTIONAL
Enrollment

408

Participants

Timeline

Start Date

May 15, 2025

Primary Completion Date

May 15, 2030

Study Completion Date

May 15, 2032

Conditions
Thyroid Cancer
Interventions
BEHAVIORAL

Decision Aid

The study intervention is a web-based decision aid (DA) developed by the study team. The Radioactive Iodine Decisions decision aid is designed as an educational tool to help patients have information about Radioactive Iodine and encourage them to talk with their medical team about this treatment decision.

BEHAVIORAL

Usual Care

Patients randomized in the Usual Care Condition arm will receive a link for the American Cancer Society website on Radioactive Iodine (Radioiodine) Therapy for Thyroid Cancer as our comparison.

Trial Locations (3)

20007

Lombardi Comprehensive Cancer Center, Washington D.C.

20010

MedStar Washington Hospital Center, Washington D.C.

22031

Inova Health System, Falls Church

All Listed Sponsors
collaborator

National Institutes of Health (NIH)

NIH

collaborator

National Institute of Dental and Craniofacial Research (NIDCR)

NIH

lead

Georgetown University

OTHER